XML 165 R121.htm IDEA: XBRL DOCUMENT v3.23.2
STOCK PROGRAMS - Narrative (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
May 18, 2021
shares
Sep. 30, 2022
shares
Mar. 31, 2021
USD ($)
shares
Feb. 28, 2018
USD ($)
tranche
shares
Sep. 30, 2015
tranche
shares
Jun. 30, 2023
USD ($)
tranche
plan
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
shares
Mar. 31, 2022
USD ($)
Sep. 04, 2015
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award                    
Number of active equity compensation plans | plan           2        
Total unrecognized compensation cost related to unvested stock-based awards | $           $ 241        
Weighted-average period over which compensation cost related to unvested stock-based awards is expected to be recognized           1 year        
Deferred compensation expense (income) to reflect additional deferrals and change in market value (in dollars) | $           $ (7) $ (33) $ 31    
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Selling, general and administrative Selling, general and administrative Selling, general and administrative    
Income tax expense (benefit) | $           $ 52 $ 51 $ 50    
Recurring basis                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Stock option liability | $           99 74      
Level 3 | Recurring basis                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Changes in fair value, net of foreign currency remeasurements | $           22 (55) 40    
Stock option liability | $           $ 99 74      
Company Stock Option Plan                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Number of substantively equal tranches in which stock options grants become exercisable | tranche           3        
DECIEM 2021 Stock Option Plan                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Vested options (in shares) 94,101                  
Exercised in period (in shares)           0        
Stock Options | Company Stock Option Plan                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Maximum exercise period for all stock options from the date of grant           10 years        
Service period over which stock option grants generally become exercisable in substantively equal tranches           4 years        
Stock Options | DECIEM 2021 Stock Option Plan                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Service period over which stock option grants generally become exercisable in substantively equal tranches           2 years        
Stock option liability | $           $ 99 74   $ 104  
Stock Options | DECIEM 2021 Stock Option Plan | Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Number of substantively equal tranches in which stock options grants become exercisable | tranche           2        
Stock Options | DECIEM 2021 Stock Option Plan | Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Number of substantively equal tranches in which stock options grants become exercisable | tranche           7        
Stock Options | DECIEM 2021 Stock Option Plan | DECIEM                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Fair value of stock options | $                 $ 295  
Restricted Stock Units (RSUs) | Employee                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Granted (in shares)           1,129,200        
Weighted-average grant date fair value (in dollars per share) | $ / shares           $ 246.20        
Vested (in shares)           744,900        
Restricted Stock Units (RSUs) | Employee | RSU grants scheduled to vest in fiscal 2024                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Vested (in shares)           400,000        
Restricted Stock Units (RSUs) | Employee | RSU grants scheduled to vest in fiscal 2025                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Vested (in shares)           300,000        
Restricted Stock Units (RSUs) | Employee | RSU grants scheduled to vest in fiscal 2026                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Vested (in shares)           400,000        
Performance Share Units | Employee                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Granted (in shares)           142,500        
Weighted-average grant date fair value (in dollars per share) | $ / shares           $ 237.79        
Vesting period           3 years        
Vested (in shares)   100,000       155,900        
Long-term Performance Share Units | Performance period ending June 30, 2018 and 2019                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Common stock anticipated to be issued (in shares)           387,848        
Cash Units                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Deferred compensation expense (income) to reflect additional deferrals and change in market value (in dollars) | $           $ (8) $ (5) $ 29    
Common Class A                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Number of Class A Common Stock shares authorized under active equity compensation plans (in shares)           88,800,000        
Number of Class A Common Stock shares reserved and available to be granted pursuant to equity compensation plans (in shares)           10,100,000        
Common stock anticipated to be issued (in shares)           1,785,100 2,689,700 3,814,300    
Common Class A | Restricted Stock Units (RSUs) | Employee                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Weighted-average grant date fair value (in dollars per share) | $ / shares           $ 246.20        
Common Class A | Performance Share Units | Employee                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Granted (in shares)           100,000        
Weighted-average grant date fair value (in dollars per share) | $ / shares           $ 246.15        
Common stock anticipated to be issued (in shares)   200,000                
Common Class A | Long-term Performance Share Units | Employee                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Common stock anticipated to be issued (in shares)           195,940        
Common Class A | Long-term Performance Share Units | Employee | Executive                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Granted (in shares)     68,578              
Payout for performance share units in Class A Common Stock (in shares)       195,940 387,848          
Number of tranches | tranche       2 3          
Grant date fair value (in USD) | $     $ 20 $ 27           $ 30
Common Class A | Long-term Performance Share Units | Employee | Performance periods ending June 30, 2018, 2019 and 2020 | Executive                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Payout for performance share units in Class A Common Stock (in shares)         129,283          
Common Class A | Long-term Performance Share Units | Employee | Share Based Compensation Award Performance Period 2021 and 2022 | Executive                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Payout for performance share units in Class A Common Stock (in shares)       97,970            
Common Class A | Long-Term Price-Vested Units | Employee | Executive                    
Share-based Compensation Arrangement by Share-based Payment Award                    
Granted (in shares)     85,927              
Grant date fair value (in USD) | $     $ 20              
Consecutive trading days     20 days